Prohibits drug, cannabis or alcohol testing of pregnant or postpartum individuals and newborns unless the individual consents and it is within the scope of medical care, or the testing is necessary for a medical emergency.

New York Senate Bill S00845 aims to protect the privacy and autonomy of pregnant and postpartum individuals by prohibiting drug, cannabis, or alcohol testing of these individuals and their newborns without consent. Exceptions are made if the testing is within the scope of medical care or necessary for a medical emergency. The bill was passed by the Senate on June 4, 2026, with a vote of 38 in favor and 22 against, and then referred to the Assembly Codes Committee.

Supporters of the bill argue that it safeguards the rights and privacy of pregnant and postpartum individuals, preventing unnecessary and potentially discriminatory testing. They believe it promotes trust between patients and healthcare providers and aligns with broader efforts to protect personal freedoms and bodily autonomy.

Opponents express concern that the bill could hinder efforts to identify and address substance use issues in pregnant individuals and newborns, potentially leading to missed opportunities for early intervention and support. They worry that it may compromise the health and safety of both mothers and infants by limiting healthcare providers' ability to conduct necessary screenings.